These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33316809)

  • 1. Management and Outcome of Venous Thrombosis in Patients with Myeloproliferative Neoplasms: Data from the Israeli MPN Working Group.
    Gutwein O; Lavi N; Barzilai M; Shacham-Abulafia A; Leader A; Chubar E; Dally N; Shapira S; Mishchenko E; Ellis M; Koren-Michowitz M
    Acta Haematol; 2021; 144(4):438-445. PubMed ID: 33316809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study.
    Martinelli I; De Stefano V; Carobbio A; Randi ML; Santarossa C; Rambaldi A; Finazzi MC; Cervantes F; Arellano-Rodrigo E; Rupoli S; Canafoglia L; Tieghi A; Facchini L; Betti S; Vannucchi AM; Pieri L; Cacciola R; Cacciola E; Cortelezzi A; Iurlo A; Pogliani EM; Elli EM; Spadea A; Barbui T
    Am J Hematol; 2014 Nov; 89(11):E200-5. PubMed ID: 25042466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events.
    Lim HY; Ng C; Donnan G; Nandurkar H; Ho P
    J Thromb Thrombolysis; 2016 Oct; 42(3):423-31. PubMed ID: 27085541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.).
    Kreher S; Ochsenreither S; Trappe RU; Pabinger I; Bergmann F; Petrides PE; Koschmieder S; Matzdorff A; Tiede A; Griesshammer M; Riess H; ; ;
    Ann Hematol; 2014 Dec; 93(12):1953-63. PubMed ID: 25307456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms.
    Arachchillage DR; Laffan M
    Semin Thromb Hemost; 2019 Sep; 45(6):604-611. PubMed ID: 31382304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients.
    Pardanani A; Lasho TL; Hussein K; Schwager SM; Finke CM; Pruthi RK; Tefferi A
    Mayo Clin Proc; 2008 Apr; 83(4):457-9. PubMed ID: 18380991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation.
    Wille K; Sadjadian P; Becker T; Kolatzki V; Horstmann A; Fuchs C; Griesshammer M
    Ann Hematol; 2019 Jan; 98(1):93-100. PubMed ID: 30155552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.
    Vossen CY; Walker ID; Svensson P; Souto JC; Scharrer I; Preston FE; Palareti G; Pabinger I; van der Meer FJ; Makris M; Fontcuberta J; Conard J; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1992-7. PubMed ID: 15976329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases.
    De Stefano V; Rossi E; Carobbio A; Ghirardi A; Betti S; Finazzi G; Vannucchi AM; Barbui T
    Blood Cancer J; 2018 Nov; 8(11):112. PubMed ID: 30420642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2V617F mutation prevalence on Chilean adults suffering from primary mesenteric and portal venous thromboses.
    González-Montero J; Del Valle-Batalla L; Castillo-Astorga R; Marín Valdés A; Conte Lanza G
    Int J Lab Hematol; 2020 Jun; 42(3):331-334. PubMed ID: 32154655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms.
    De Stefano V; Finazzi G; Barbui T
    Blood Cancer J; 2018 Jun; 8(7):65. PubMed ID: 29946112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms.
    Hoekstra J; Bresser EL; Smalberg JH; Spaander MC; Leebeek FW; Janssen HL
    J Thromb Haemost; 2011 Nov; 9(11):2208-14. PubMed ID: 22040061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent venous thromboembolism in a Spanish population: incidence, risk factors, and management in a hospital setting.
    Grau E; Real E; Medrano J; Pastor E; Selfa S
    Thromb Res; 1999 Dec; 96(5):335-41. PubMed ID: 10605948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: a physician survey.
    Ellis MH; Lavi N; Vannucchi A; Harrison C
    Thromb Res; 2014 Aug; 134(2):251-4. PubMed ID: 24842684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
    Sant'Antonio E; Guglielmelli P; Pieri L; Primignani M; Randi ML; Santarossa C; Rumi E; Cervantes F; Delaini F; Carobbio A; Betti S; Rossi E; Lavi N; Harrison CN; Curto-Garcia N; Gisslinger H; Gisslinger B; Specchia G; Ricco A; Vianelli N; Polverelli N; Koren-Michowitz M; Ruggeri M; Girodon F; Ellis M; Iurlo A; Mannelli F; Mannelli L; Sordi B; Loscocco GG; Cazzola M; De Stefano V; Barbui T; Tefferi A; Vannucchi AM
    Am J Hematol; 2020 Feb; 95(2):156-166. PubMed ID: 31721282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding complications in bcr-abl-negative myeloproliferative neoplasms (MPN): A retrospective single-center study of 829 MPN patients.
    Wille K; Huenerbein K; Jagenberg E; Sadjadian P; Becker T; Kolatzki V; Meixner R; Marchi H; Fuchs C; Griesshammer M
    Eur J Haematol; 2022 Feb; 108(2):154-162. PubMed ID: 34719056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome].
    Melikyan AL; Subortseva IN; Koloshejnova EA; Gilyazitdinova EA; Shashkina KS; Gorgidze LA; Tratsevskaya ZV; Margolin OV
    Ter Arkh; 2019 Jul; 91(7):93-99. PubMed ID: 32598741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilia, clinical factors, and recurrent venous thrombotic events.
    Christiansen SC; Cannegieter SC; Koster T; Vandenbroucke JP; Rosendaal FR
    JAMA; 2005 May; 293(19):2352-61. PubMed ID: 15900005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.